Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MT3 logo — Advancing radiosensitizer technology to treat animal tumors...

MT3

Advancing radiosensitizer technology to treat animal tumors with innovative therapeutic solutions.

Founded 2018 Seed Health Care

General Information

Company Name MT3
Founded Year 2018
Industries Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with MT3. To contact MT3, visit mt3.co.jp.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About MT3

MT3 is a health care startup that is advancing radiosensitizer technology to treat animal tumors with innovative therapeutic solutions. Founded in 2018, the company focuses on providing treatment to animals suffering from tumors by offering therapeutic agents, treating various forms of tumors, and providing anti-tumor treatment. In their latest milestone, MT3 received a Seed Round investment on 19 November 2020 from investors including REVIC and Gungin Consulting. This investment is a testament to the potential of MT3's pioneering technology in the field of animal tumor treatment.

Taxonomy: radiosensitizer technology, animal tumors, therapeutic solutions, treatment, therapeutic agents, anti-tumor treatment

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 2
REVIC
REVIC, Gungin Consulting
19 Nov 2020

MT3 Alternatives & Competitors

View All Alternatives
MT3 vs
Arrogene, Inc.
Arrogene, Inc.

Innovative cancer treatment technology delivering advanced nano agents to target tumors, enhancing p...

Venture round
1 employees
Biotechnology, Health Care
MT3 vs
Shasqi
Shasqi United States

Targeting cancer with click chemistry

Series B
28 employees
Biotechnology, Health Care
MT3 vs
PhenoTech
PhenoTech

Pioneering the future of hematology with innovative diagnostic and therapeutic solutions for optimal...

Seed
Biotechnology, Health Care
View all alternatives

FAQ About MT3

Advancing radiosensitizer technology to treat animal tumors with innovative therapeutic solutions.
MT3 was founded in 2018.
MT3 operates in Health Care. Its work centres on radiosensitizer technology, animal tumors, therapeutic solutions and treatment.
MT3 has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to MT3 include Arrogene, Inc., Shasqi, PhenoTech, Navignostics AG, Harpoon Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MT3 and Arrogene, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MT3, https://bouncewatch.com/company/mt3, updated 26 July 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes